More reliable and more predictable Aligner Therary.
Real-Time Treatment AI Monitoring and Management Platform.
Data Capture and Assessment of Aligner Prescription Software that matches progress.
The first real-time AI Driven wearable Aligner Technology in over 20 years - making Aligner engager placement quicker and more certain while managing and monitoring Aligner Therapy and during and post-treatment. Three revolutionary patent-pending products and processes making Aligner Therapy more reliable and predictable than never before. Beta Testing is free and AlignerAI will be working with 100 Dentists and 500 clients over three months. It is a great opportunity to be the first to try this amazing product and be first in line for Dentist Pre-Sales in June 2024.
Three Revolutionary products taking Aligner Therapy to the next level for Dentist and client.
AlignerAI is a product created and developed by Dentists for Dentists.
Our own proprietary Orthodontic Aligner prescription software to identify best-case treatment with the revolutionary patent-pending AlignerAi multi-engager pre-fillable template managed by our AI Platform.
Real-Time management and monitoring of treatment progress with our Patent Pending 'IntelliTrak Bite Analysis' to identify treatment efficacy and outcome via TrackRX Report to Dental professionals.
AI Management is performed by simple weekly at-home data capture by client using their mobile phone camera and matched against the therapy prescription software and Bite Analysis Imagery.
AlignerAi is the first A.I. driven Aligner therapy platform to treat and manage Aligner therapy from start to completion. Its novel patent pending processes will drive Dentist revenue and provide an easier and more reliable treatment journey for patients.
Over the next six years the clear Aligner industry is set to explode from a current $6.9BN to a massive $44BN global business by 2030. As legacy brand patents expire and dozens of new Aligner companies are entering the global market. But, the problem for them all is that their technology is old in fact more than 20 years old. If you are reading this website you are in a select group of people with the opportunity of Investing in AlignerAi. If you missed on Invisalign at the start, it is now a $16BN Aligner company, then AlignerAi may be for you. Investments in AlignerAi have IRS Stock 1244 code - keeping your money safe.
We ask you to respect our confidentiality and non-disclosure of the contents of our Deck. You can view it below providing you agree to that confidentiality and non-disclosure and be directed to the Deck..
I believe this technology is a game-changer for Dentists and clients undergoing Aligner Therapy. It delivers quicker, more reliable and more predictable treatment and solves a lot of problems for Dentists wanting to enter the Aligner Therapy marketplace. The clear Aligner market is expanding rapidly - AlignerAi is the product to meet that expansion.
AlignerAi provides a revolutionary treatment protocol and makes it easier for any Dentist to choose the 'best product' for their clients. Being a Dentist driven product, clients have complete protection against at-home based Aligner therapy products. It can drive Dentist revenue by saving time and keeping patient costs stable.
We have been extremely fortunate to find the world's best piezochromic polymer lab and partner with them. Having our AI platform provides real-time monitoring and management and changes how treatment protocols keep therapy outcomes effective, with a simple to use client-faced mobile phone App that captures treatment data.
AlignerAi uses a multi positioning pre-fillable engager template that allows the Dentist to quickly bond ALL the engagers at one time instead of one-by-one and just taking a few minutes instead of an hour or more.
AlignerAi uses a Patent Pending piezochromic mouth-guard that monitors positional changes. These changes including lateral, up and down and rotational changes are captured in the pressure sensitive material and data is assessed by our AI App.
The piezochromic positional monitoring also can quickly capture molar intrusion and extrusion and then provide in-treatment remedies.
Every two weeks during treatment and post-treatment, the App captures images of the patient's teeth, assess change and creates a IntelliTrack Report sent to the Dentist.
BOSTON, US: The use of artificial intelligence (AI) in remote monitoring for clear aligner therapy is becoming increasingly popular and promising greater clinical control and an improved patient experience.
HOUSTON, US: The flag-bearer for at-home clear aligner therapy has filed for Chapter 11 bankruptcy protection in the US, signalling a potential shake-up in the market for remote orthodontic therapy. Plagued by a litany of lawsuits and economic setbacks, SmileDirectClub (SDC) will cease its operations if it cannot secure a financial lifeline by 23 November.
BURNABY, British Columbia, Canada: The global clear aligner market was valued at approximately US$5.2 billion (€4.8 billion) in 2022 and is expected to reach $40BN by 2030 at a CAGR of 28%.
